BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 33157223)

  • 1. Astragaloside IV inhibits protein tyrosine phosphatase 1B and improves insulin resistance in insulin-resistant HepG2 cells and triglyceride accumulation in oleic acid (OA)-treated HepG2 cells.
    Zhou X; Wang LL; Tang WJ; Tang B
    J Ethnopharmacol; 2021 Mar; 268():113556. PubMed ID: 33157223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fucosterol activates the insulin signaling pathway in insulin resistant HepG2 cells via inhibiting PTP1B.
    Jung HA; Bhakta HK; Min BS; Choi JS
    Arch Pharm Res; 2016 Oct; 39(10):1454-1464. PubMed ID: 27544192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1.
    Ziamajidi N; Khaghani S; Hassanzadeh G; Vardasbi S; Ahmadian S; Nowrouzi A; Ghaffari SM; Abdirad A
    Food Chem Toxicol; 2013 Aug; 58():198-209. PubMed ID: 23603006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astragaloside IV Inhibits Triglyceride Accumulation in Insulin-Resistant HepG2 Cells via AMPK-Induced SREBP-1c Phosphorylation.
    Wang C; Li Y; Hao M; Li W
    Front Pharmacol; 2018; 9():345. PubMed ID: 29713279
    [No Abstract]   [Full Text] [Related]  

  • 5. Prunin is a highly potent flavonoid from Prunus davidiana stems that inhibits protein tyrosine phosphatase 1B and stimulates glucose uptake in insulin-resistant HepG2 cells.
    Jung HA; Ali MY; Bhakta HK; Min BS; Choi JS
    Arch Pharm Res; 2017 Jan; 40(1):37-48. PubMed ID: 27798765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydrocurcumin ameliorates the lipid accumulation, oxidative stress and insulin resistance in oleic acid-induced L02 and HepG2 cells.
    Yu Q; Liu Y; Wu Y; Chen Y
    Biomed Pharmacother; 2018 Jul; 103():1327-1336. PubMed ID: 29864915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigating the effects of compound WS090152 on non-alcoholic fatty liver in mice].
    Zhou Y; Li XL; Yi Q; Zhang XL; Tian JY; Wang DM; Wu S; Ye F
    Yao Xue Xue Bao; 2016 Jun; 51(6):919-25. PubMed ID: 29879345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Methyl artoflavanocoumarin from Juniperus chinensis exerts anti-diabetic effects by inhibiting PTP1B and activating the PI3K/Akt signaling pathway in insulin-resistant HepG2 cells.
    Jung HJ; Seong SH; Ali MY; Min BS; Jung HA; Choi JS
    Arch Pharm Res; 2017 Dec; 40(12):1403-1413. PubMed ID: 29177868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of silibinin on CFLAR-JNK pathway in oleic acid-treated HepG2 cells.
    Liu Y; Yu Q; Chen Y
    Biomed Pharmacother; 2018 Dec; 108():716-723. PubMed ID: 30248539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of daphnetin on lipid metabolism, insulin resistance and oxidative stress in OA‑treated HepG2 cells.
    Liu Y; Liao L; Chen Y; Han F
    Mol Med Rep; 2019 Jun; 19(6):4673-4684. PubMed ID: 30957185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin-resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice.
    Liu ZQ; Liu T; Chen C; Li MY; Wang ZY; Chen RS; Wei GX; Wang XY; Luo DQ
    Toxicol Appl Pharmacol; 2015 May; 285(1):61-70. PubMed ID: 25796170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
    Fu D; Cui H; Zhang Y
    Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligonol promotes glucose uptake by modulating the insulin signaling pathway in insulin-resistant HepG2 cells via inhibiting protein tyrosine phosphatase 1B.
    Bhakta HK; Paudel P; Fujii H; Sato A; Park CH; Yokozawa T; Jung HA; Choi JS
    Arch Pharm Res; 2017 Nov; 40(11):1314-1327. PubMed ID: 29027136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trivaric acid, a new inhibitor of PTP1b with potent beneficial effect on diabetes.
    Sun W; Zhang B; Zheng H; Zhuang C; Li X; Lu X; Quan C; Dong Y; Zheng Z; Xiu Z
    Life Sci; 2017 Jan; 169():52-64. PubMed ID: 27871946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Protein Tyrosine Phosphatase 1B Inhibitor-Geranylated Flavonoid from Mulberry Leaves Ameliorates Insulin Resistance.
    Niu SL; Tong ZF; Zhang Y; Liu TL; Tian CL; Zhang DX; Liu MC; Li B; Tian JL
    J Agric Food Chem; 2020 Aug; 68(31):8223-8231. PubMed ID: 32650643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HM-chromanone from Portulaca oleracea L. inhibits protein tyrosine phosphatase 1B and mitigates glucose production in insulin-resistant HepG2 cells.
    Lim HJ; Park JE; Han JS
    Fitoterapia; 2023 Jun; 167():105512. PubMed ID: 37080256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Swertiamarin ameliorates oleic acid induced lipid accumulation and oxidative stress by attenuating gluconeogenesis and lipogenesis in hepatic steatosis.
    Patel TP; Rawal K; Soni S; Gupta S
    Biomed Pharmacother; 2016 Oct; 83():785-791. PubMed ID: 27490779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astragaloside IV attenuates free fatty acid-induced ER stress and lipid accumulation in hepatocytes via AMPK activation.
    Zhou B; Zhou DL; Wei XH; Zhong RY; Xu J; Sun L
    Acta Pharmacol Sin; 2017 Jul; 38(7):998-1008. PubMed ID: 28344322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triterpenic acids-enriched fraction from Cyclocarya paliurus attenuates insulin resistance and hepatic steatosis via PI3K/Akt/GSK3β pathway.
    Zheng X; Zhao MG; Jiang CH; Sheng XP; Yang HM; Liu Y; Yao XM; Zhang J; Yin ZQ
    Phytomedicine; 2020 Jan; 66():153130. PubMed ID: 31790897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Didymin, a dietary citrus flavonoid exhibits anti-diabetic complications and promotes glucose uptake through the activation of PI3K/Akt signaling pathway in insulin-resistant HepG2 cells.
    Ali MY; Zaib S; Rahman MM; Jannat S; Iqbal J; Park SK; Chang MS
    Chem Biol Interact; 2019 May; 305():180-194. PubMed ID: 30928401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.